0 Σχόλια
0 Μοιράστηκε
1χλμ. Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Opportunity Analysis Report"According to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period The winning Dual GIP/ GLP-1 Receptor Agonists...0 Σχόλια 0 Μοιράστηκε 165 Views 0 Προεπισκόπηση
-
GLP-1 Agonists Weight Loss Drugs Market Supply Chain AnalysisThe global GLP-1 Agonists Weight Loss Drugs Market was valued at USD 13.8 billion in 2024 and is projected to grow from USD 27.5 billion in 2026 to USD 48.8 billion by 2030, registering a CAGR of 18.5% from 2025 to 2030. North America dominated the market with a 75.5% revenue share in 2024, supported by high obesity prevalence, favorable reimbursement policies, strong pharmaceutical...0 Σχόλια 0 Μοιράστηκε 413 Views 0 Προεπισκόπηση
-
GLP-1 Drug Market – Manufacturing Scale-Up Addressing Supply ConstraintsMarket Overview The global GLP-1 drug market is witnessing massive manufacturing investments as pharmaceutical companies race to expand production capacity and address persistent supply constraints limiting patient access. The GLP-1 Drug Market is experiencing unprecedented demand that exceeds current manufacturing capabilities, driving billions in capital investment for new production...0 Σχόλια 0 Μοιράστηκε 114 Views 0 Προεπισκόπηση
-
GLP-1 Receptor Agonists Obesity Drugs Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032, at a CAGR of 16.21% during the forecast period Attaining...0 Σχόλια 0 Μοιράστηκε 278 Views 0 Προεπισκόπηση
-
Peptide Drugs For Diabetes Market: GLP-1 Agonists and Injectable Segment Driving GrowthThe Peptide Drugs For Diabetes Market is experiencing significant and steady growth, with specific drug class and administration route segments acting as primary catalysts. The market, valued at USD 6.3 Billion in 2024, is projected to reach USD 11.2 Billion by 2032, driven by a global imperative for effective and comprehensive diabetes management. The GLP-1 agonists drug...0 Σχόλια 0 Μοιράστηκε 181 Views 0 Προεπισκόπηση
-
Diabetes & Obesity Treatment Trends in GLP-1 Agonists Market"Glucagon-Like Peptide 1 (GLP-1) Agonists Market Summary: According to the latest report published by Data Bridge Market Research, the Glucagon-Like Peptide 1 (GLP-1) Agonists Market The glucagon-like peptide 1 (GLP-1) agonists is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the glucagon-like peptide 1 (GLP-1) agonists market...0 Σχόλια 0 Μοιράστηκε 411 Views 0 Προεπισκόπηση
-
Global Dual GIP/GLP-1 Receptor Agonists Obesity Drugs Market: Therapeutic Innovation, Obesity Treatment Trends, Demand, and Growth OutlookAccording to the latest report published by Data Bridge Market Research, the Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market CAGR Value The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast...0 Σχόλια 0 Μοιράστηκε 159 Views 0 Προεπισκόπηση
-
Global GLP-1 Market Trends: Next-Gen Metabolic Therapies"Executive Summary Glucagon-Like Peptide 1 (GLP-1) Agonists Market Research: Share and Size Intelligence The glucagon-like peptide 1 (GLP-1) agonists is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the glucagon-like peptide 1 (GLP-1) agonists market was valued at 12.55 billion in 2021 and is likely to reach USD 20.15 billion by...0 Σχόλια 0 Μοιράστηκε 153 Views 0 Προεπισκόπηση
-
GLP-1 Analogues Market Trends: Increasing Demand for Weight Management Fuels Industry ExpansionThe global GLP-1 Analogues Market is witnessing remarkable expansion as the healthcare industry embraces innovative therapies that address two of the world's most pressing public health challenges—type 2 diabetes and obesity. Rising prevalence of metabolic disorders, growing demand for effective weight management treatments, and continuous pharmaceutical innovation are fueling significant...0 Σχόλια 0 Μοιράστηκε 169 Views 0 Προεπισκόπηση
-
GLP-1 Drug Market – Emerging Indications Beyond Diabetes and ObesityMarket Overview The GLP-1 Drug Market is exploring therapeutic applications far beyond established diabetes and obesity indications, with promising evidence emerging in neurodegenerative diseases, addiction disorders, non-alcoholic steatohepatitis, and polycystic ovary syndrome. The pleiotropic effects of GLP-1 receptor activation on inflammation, neuroprotection, and metabolic regulation...0 Σχόλια 0 Μοιράστηκε 81 Views 0 Προεπισκόπηση
-
GLP-1 Drug Market – Oral Therapies Expand Access Beyond Injectable CareOral GLP-1 therapies are emerging as an important opportunity in the GLP-1 drug market. While subcutaneous injections currently dominate with approximately 64% market share, oral formulations are expected to grow quickly as patients seek less invasive and more convenient treatment options.marketresearchfuture Injectable GLP-1 therapies remain central to the market because they have established...0 Σχόλια 0 Μοιράστηκε 119 Views 0 Προεπισκόπηση
-
Therapeutic Radiopharmaceuticals MarketPotential: Size, Share, Trends, and Future Outlook"Future of Executive Summary GLP-1 Analogues Market: Size and Share Dynamics The global GLP-1 analogues market size was valued at USD 32.19 billion in 2024 and is expected to reach USD 346.06 billion by 2032, at a CAGR of 34.56% during the forecast period To thrive in this rapidly transforming marketplace, today’s businesses call for innovative and...0 Σχόλια 0 Μοιράστηκε 740 Views 0 Προεπισκόπηση
-
Diabetes Treatments Market Size, Share, and Growth Forecast to 2030According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...0 Σχόλια 0 Μοιράστηκε 5χλμ. Views 0 Προεπισκόπηση
-
Emerging Trends in the GLP-1 Agonists Industry"Glucagon-Like Peptide 1 (GLP-1) Agonists Market Summary: According to the latest report published by Data Bridge Market Research, the Glucagon-Like Peptide 1 (GLP-1) Agonists Market The glucagon-like peptide 1 (GLP-1) agonists is supportive and aims to reduce the severity of the symptoms. Data Bridge Market Research analyses that the glucagon-like peptide 1 (GLP-1) agonists market...0 Σχόλια 0 Μοιράστηκε 170 Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Bengali